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Abstract  21 
 22 
The possible impact of carbamazepine (CBZ) and propranolol (PROP), two widespread 23 
pharmaceuticals in the aquatic environment, were investigated on morphology and gene 24 
transcription of early larvae of Mytilus galloprovincialis. Pharmaceuticals were first tested 25 
in a wide concentration range (from 0.01 to 1000 µg/L) through the 48-hpf embryotoxicity 26 
assay. The results showed that both compounds significantly affected embryo 27 
development from environmental concentrations. Although similar EC50 were obtained, ( 28 
1 g/L) CBZ induced a progressive increase in embryo malformations, whereas PROP 29 
apparently showed greater impacts in terms of arrested development and embryo mortality 30 
at higher concentrations (>10 g/L). Transcriptional analyses of 17 genes involved in 31 
different physiological functions in mussels and/or in their response to environmental 32 
contaminants, were performed at 24 and 48 h pf at two selected concentrations of CBZ 33 
and PROP (0.01 and 1 µg/L). Both compounds induced down-regulation of shell-specific 34 
and neuroendocrine related transcripts, while distinct effects were observed on 35 
antioxidant, lysosomal, and immune-related transcripts, also depending on the larval stage 36 
investigated. The results demonstrate that CBZ and PROP can affect development and 37 
gene transcription in mussel early larvae at environmental concentrations.  38 
 39 
Keywords: mussel embryo development; pharmaceutical; carbamazepine; propranolol; 40 
embryotoxicity; gene transcription.  41 
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1 Introduction 42 
Pharmaceuticals are biologically active molecules used in human and veterinary 43 
medicine, which are partially excreted as parent compounds or active metabolites and 44 
enter wastewater treatment plants (WWTP). Given their increased consumption and low-45 
retention in WWTP, as well as the development of more powerful analytical techniques, 46 
pharmaceuticals have been widely detected in the marine environment, mainly in coastal 47 
areas (Fabbri and Franzellitti, 2016). Although half-life of these compounds is relatively 48 
short, the marine biota is exposed to a continuous input, raising concern on the potential 49 
biological impacts (Fent et al., 2006). Research efforts over the last decade also pointed 50 
out that pharmaceuticals may affect marine fauna at environmental concentrations when 51 
specific responses related to the therapeutic targets or the modes of action known in 52 
humans are investigated (Brooks, 2018; Fabbri and Franzellitti, 2016).  53 
Amongst the pharmaceuticals routinely detected in coastal environments, 54 
carbamazepine (CBZ) and propranolol (PROP) attracted special attention when it was 55 
proved that they induced sublethal effects in marine invertebrates, including mussels 56 
(Fabbri and Franzellitti, 2016), and a link between these effects and the therapeutic modes 57 
of action in humans was revealed (Franzellitti et al., 2013, 2011; Martin-Diaz et al., 2009).  58 
Carbamazepine (CBZ) is an antiepileptic drug which poorly retained during wastewater 59 
treatments (below 10%), thus it is found in all aquatic compartments, including drinking 60 
waters, at the low μg/L concentration range (Bahlmann et al., 2012; Calisto et al., 2011; 61 
Metcalfe et al., 2014). In seawater, CBZ was documented in harbours (up to 321 ng/L), 62 
coastal waters (up to 1400 ng/L) and sediments (up to 89 ng/g), and in river estuaries (up 63 
to 178 ng/L) (Fabbri and Franzellitti, 2016). Propranolol (PROP) is administered to 64 
counteract hypertension and other cardiovascular pathologies. It is found in surface waters 65 
(ng/L range), in transitional waters (up to 142 ng/L), coastal waters (up to 6329 ng/L) and 66 
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sediments (up to 0.9 ng/g) (Ashton et al., 2004; Fabbri and Franzellitti, 2016; Wille et al., 67 
2011). Data on occurrence of both pharmaceuticals in seawater are summarized in Table 68 
S1, Supplemental material.  69 
Recent studies indicated that embryos/larvae from different species can be utilized as 70 
promising experimental models to establish the sensitivity of marine species towards 71 
pharmaceuticals (Balbi et al., 2016; Di Poi et al., 2017, 2014; Estévez-Calvar et al., 2017; 72 
Fabbri et al., 2014; Franzellitti et al., 2017; Minguez et al., 2014). Compounds with widely 73 
different therapeutic effects and chemical reactivity have been shown to affect early larval 74 
development in the Mediterranean mussel, Mytilus galloprovincialis (Balbi et al., 2016; 75 
Estévez-Calvar et al., 2017; Fabbri et al., 2014). In particular, 17β-estradiol and diclofenac 76 
altered the transcription of genes involved in shell biogenesis and serotonin signaling 77 
(Balbi et al., 2018, 2016). 78 
This study is addressed to the potential effects of CBZ and PROP on early larval 79 
development of M. galloprovincialis. Phenotypical outcomes of the pharmaceuticals were 80 
investigated in a wide concentration range (0.01 – 1000 µg/L) through the standardized 81 
48-hpf embryotoxicity assay (Fabbri et al., 2014) which evaluates the impairment of normal 82 
D-larvae development. Moreover, transcriptional analyses of 17 gene products at different 83 
developmental stages (24 and 48 h post fertilization, pf)  (Balbi et al., 2017a, 2016) were 84 
carried out after exposure to two selected CBZ or PROP concentrations (0.01 and 1 µg/L). 85 
As both compounds may affect physiological pathways in bivalves (Fabbri and Capuzzo, 86 
2010; Franzellitti et al., 2017; Franzellitti and Fabbri, 2013), this latter experimental 87 
approach aimed to disclose early signs of CBZ/PROP interactions with developmental 88 
processes of mussels.  89 
 90 
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2 Methods  91 
2.1 Chemicals 92 
Carbamazepine (CBZ), and (±)-propranolol hydrochloride (PROP) were at the 93 
molecular biology grade (> 99 % purity) and were purchased from Sigma Aldrich (Milan, 94 
Italy). The DirectZol kit was from Zymo Research (Freiburg, Germany). The Qubit RNA 95 
assay and the Qubit protein assay were from Thermo Fisher (Milan, Italy). The iScript 96 
supermix and iTaq Universal master mix with ROX were from Biorad Laboratories (Milan, 97 
Italy). The Tri-Reagent, dimethylsulfoxide (DMSO), and any other reagent was from Sigma 98 
Aldrich (Milan, Italy).  99 
 100 
2.2 Mussels and gamete collection  101 
Sexually mature mussels (M. galloprovincialis Lam.) were obtained from a certified 102 
mussel farm (Cooperativa Copr.al.mo, Cesenatico, Italy) and acclimatized in static tanks 103 
containing aerated artificial 35-psu seawater (ASTM, 2004) at 16 ± 1 °C (1 L/animal). 104 
Procedures for gamete collection, oocyte fertilization and larvae handling were according 105 
to Fabbri et al. (2014). Fertilizations were performed with an egg:sperm ratio 1:10 in 96-106 
well (embryotoxicity assay; 200 µL final volume) or 6-well (transcriptional analyses; 10 mL 107 
final volume) cell culture plates. After 30 min, fertilization success (n. fertilized eggs / n. 108 
total eggs × 100) was verified by microscopical observation (>85%) and carbamazepine 109 
(CBZ) or propranolol (PROP) were added to fertilized eggs in the proper wells from 110 
concentrated stock solutions prepared in DMSO (CBZ) or sterile milli-Q water (PROP), 111 
considering solubility limits of the compounds in the selected medium, and diluted in ASW 112 
to reach the final nominal concentrations tested. Concentrations of the stock solutions 113 
were verified by LC-MS/MS (Castiglioni et al., 2005). They were within a 8% discrepancy 114 
compared to the nominal values. DMSO final concentration never exceeded 0.1% v/v and 115 
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it did not significantly affect the biological endpoints analysed (data not shown). Control 116 
(ASW) and solvent (ASW+DMSO; 0.1% v/v) exposed samples were run in parallel. After 117 
pharmaceutical addition, samples were maintained at 16 ± 1 °C for 48 h with a 16 h:8 h 118 
light:dark photoperiod according to ASTM (2004).  119 
2.3 Embryotoxicity assay   120 
The 48-h embryotoxicity assay (ASTM, 2004) was performed according to Fabbri et 121 
al. (2014) and using a wide range of nominal concentrations from 0.01 to 1000 µg/L. Four 122 
independent experiments were performed, each consisting of 6 technical replicates (N = 123 
4). At the end of the incubation time, samples were fixed with buffered formalin (4%). For 124 
each well, all larvae were examined by optical and/or phase contrast microscopy using an 125 
inverted microscope (Olympus IX53, Olympus, Milan, Italy) at 40X magnification. 126 
Observations were carried out by an operator blind to the experimental conditions. 127 
Classification of larvae morphotypes was performed according to Balbi et al. (2017a) and 128 
Fabbri et al. (2014), with the recorded endpoint being the percentage of normal D-shape 129 
larvae in each well over the total. The acceptability of assay results was achieved with 130 
controls showing a > 75% normal D-shape larvae (ASTM, 2004).  131 
According to the ASTM guidelines (ASTM, 2004), embryo viability at 48 h pf was 132 
assessed as the percentage of live larvae with misshapen or otherwise malformed shells 133 
and completely/normally developed shells. Empty shells, larvae with incompletely 134 
developed shells or larvae retained at the trocophora stage were considered non-viable 135 
because retarded development is likely to reduce survival in the natural environment 136 
(ASTM, 2004).  137 
 138 
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2.4 RNA extraction and qPCR analyses  139 
Treatments for mRNA expression analyses were carried out at 0.01 μg/L and 1 μg/L. 140 
Four independent experiments were performed, each consisting of 3 technical replicates 141 
(N = 4). Total RNA extraction from embryos at 24 h and 48 h pf was performed according 142 
to Balbi et al. (2016). RNA concentration and quality were verified using the Qubit RNA 143 
assay through the Qubit 2.0 system (Thermo Fisher, Milan, Italy) and electrophoresis 144 
using a 1.2% agarose gel under denaturing conditions. First strand cDNA for each sample 145 
was synthesized from 1 µg total RNA using the iScript supermix following manufacturer’s 146 
instructions. Target transcripts are listed in Table S2, Supplemental material. Primer pairs 147 
and protocols employed for quantitative real time PCR (qPCR) assays are reported in 148 
previous studies (Balbi et al., 2017a, 2016; Capolupo et al., 2018). A preliminary stability 149 
analysis performed according to Balbi et al. (2016) selected the pair helicase/elongation 150 
factor 1α as the reference gene products for qPCR data normalization. A comparative CT 151 
method was used for fold-change calculations (Schmittgen and Livak, 2008) through the 152 
StepOne software tool (Thermo Fisher, Milan, Italy). Data are reported as mean ± SEM of 153 
log2-transformed fold changes with respect to controls within each post-fertilization time. 154 
Expressions of transcripts related to antioxidant responses, immune responses and 155 
lysosomal functions were also evaluated in unfertilized eggs as well as in 24- and 48-h pf 156 
embryos grown under normal physiological conditions, to account for their baseline 157 
regulation across early embryo development (Fig. S1, Supplemental material)  158 
 159 
2.5 Statistics 160 
Data from embryotoxicity and embryo viability were analysed using the non-parametric 161 
1-way ANOVA (Kruskal-Wallis test) and the Mann-Whitney U-test for pairwise 162 
comparisons by the GraphPad Prism 6 software (GraphPad Inc.). Non-accomplishment of 163 
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parametric ANOVA assumptions was verified (Normality: Shapiro-Wilk’s test; equal 164 
variance: F-test). EC50 values for the embryotoxicity were calculated using the Hill 165 
equation for non-linear regression through the Excel™ macro REGTOX (Vindimian, 2012). 166 
qPCR data were analysed with the REST software (Pfaffl et al., 2002) that employs 167 
randomisation tests with pairwise reallocations to assess the significance differently 168 
expressed transcripts between each treatment-exposed group and the controls. Further 169 
comparisons between pair of treatments were performed using the Mann-Whitney U-test. 170 
In all approaches, p < 0.05 was set as the threshold level of statistical significance.  171 
Data from qPCR investigations were further submitted to permutation multivariate 172 
analysis of variance (PERMANOVA) and distance-based redundancy linear modeling 173 
(DISTLM) as detailed by (Balbi et al., 2016). Factors considered were “developmental 174 
stage” and “treatment” (CBZ or PROP). DISTLM with a test of marginality was also 175 
performed to account for the contributions of the functional groups of transcripts listed in 176 
Table S2 in explaining the total variance observed in the CBZ/PROP dataset (Rasika 177 
Wathsala et al., 2018).  178 
 179 
3 Results 180 
3.1 Effects of CBZ and PROP on embryo development 181 
Fertilized eggs were exposed to different concentrations (from 0.01 µg/L to 1000 µg/L) of 182 
PROP or CBZ in 96-microwell plates, and the percentage of normal D-larvae was 183 
evaluated 48 hpf (Fig. 1). Both compounds induced a significant decrease in percentage of 184 
normally developed embryos from 0.1 μg/L (CBZ) and 0.01 µg/L (PROP) (p < 0.05), with 185 
values decreasing thereafter (Fig. 1A, B). 186 
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  187 
Fig. 1. Effects of different concentrations of CBZ or PROP (0.01 – 1000 μg/L) on M. galloprovincialis 188 
embryo development. (A, CBZ; B, PROP) Results of the 48-h embryotoxicity assay. (C) Representative 189 
light microscope images (32X magnification) showing the main types of abnormalities observed: (i) normal 190 
48 h pf D-shaped veliger; (ii) D-shaped 48 h pf veliger with protruding mantle; (iii) D-shaped veliger with shell 191 
hinge malformations; (iv) embryo arrested at the trochophora stage (characteristic of PROP-treated 192 
samples). (D) Percentage of embryo viability at 48 h pf. All data are reported as mean ± SEM of 4 193 
experiments carried out in 96-multiwell plates (6 replicate wells for each sample) (N = 4). *p < 0.05 vs control 194 
(Mann-Whitney U-test). Colored figure is intended only for the online and PDF version.  195 
 196 
Although similar EC50 values were obtained for CBZ and PROP (0.82  0.36 and 1.34  197 
0.43 µg/L, respectively), CBZ mainly induced the development of malformed D-veligers at 198 
all the concentrations tested, whereas exposure to PROP resulted in a variable proportion 199 
of malformed/immature embryos at different concentrations, with all embryos retained at 200 
the trocophora stage at the highest concentration tested (1000 µg/L) (Fig. 1C). 201 
















































































proportion of viable embryos at 48 h pf was significantly reduced at 10-1000 µg/L PROP 203 
(Fig. 1D).  204 
3.2 Effects of CBZ and PROP on gene transcription  205 
Gene transcription was evaluated in samples exposed to CBZ or PROP at 0.01 and 1 206 
µg/L. The former concentration encompasses the environmental levels of both compounds 207 
(10 ng/L, Table S1); the latter is close similar to the EC50 values obtained for both 208 
compounds in the embryotoxicity assay, and also represents the highest range of 209 
concentrations measured in coastal environments (1000 ng/L, Table S1).  210 
Selected transcripts related to different physiological functions were evaluated: 211 
Antioxidant response: Catalase, CAT; Glutathione transferase-pi, GST; Metallotionein 10 212 
and 20, MT10 and MT20; Superoxide dismutase, SOD. Immune response: Lysozyme, 213 
LYS; Mytlin B, MytlB; Myticin C; MytcC. Lysosomal response Catheplsin L, CTSL; ß-214 
Glucuronidase, GUSB; Hexosaminidase, HEX. Putative Neuroendocrine signaling: Type 1 215 
estrogen receptor, MeER1; Type 2 estrogen receptor, MeER2; Type 1 serotonin (5-HT) 216 
receptor, 5-HT1. Shell biogenesis: Extrapallial protein, EP; Carbonic anhydrase, CA. 217 
(Balbi et al., 2018, 2017a, 2016) (Details are provided in Table S2). 218 
To help comparing overall transcriptional responses among transcripts as well as datasets, 219 
fold change variations (log2-transformed) were subjected to similarity analysis which 220 
generated heatmaps describing the overall transcriptional responses to CBZ and PROP 221 
(Fig. 2). Details of results and statistics are reported in Fig. S2.  222 
Exposure to CBZ for 24h significantly up-regulated a series of transcripts (CA, CTSL, EP, 223 
LYS, HEX, MeER2 Mt10, Mt20, MytB, 5HT1 and SOD) at 0.01 µg/L. The effects of 0.01 224 
µg/L CBZ on antioxidant related transcripts were slightly reduced at 48 h pf, except for 225 
GST which appeared significantly downregulated. 226 
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 227 
Fig. 2 Heatmaps comparing changes in mRNA levels in early larval stages of M. galloprovincialis after 228 
exposure to CBZ or PROP. Clustering was performed using fold change variations (log2-transformed) of 229 
target transcripts compared to unfertilized eggs (ctr). Colors represent relative expression levels with respect 230 
to controls. Transcripts are listed in alphabetical order (see Fig. S2 for detailed data and statistics). 231 
 232 
Significant upregulation was observed for CTSL and GUSB, and downregulation for EP, 233 
MeER2, and 5HT1 (Fig. 2, Fig. S2). Significant up regulation of CA, CTSL, LYS, MT20 and 234 
MytB transcripts was observed after 24 h pf at 1 µg/L CBZ. A general downregulation is 235 
shown at 48 h pf, with the exception of HEX (up-regulated) and MeER1 and MT20 236 
(unchanged).  237 
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Exposure to PROP for 24h differently affected gene transcription, with significant down 238 
regulation of GUSB, MeER1 and 5HT1, and up-regulation of CS transcripts at 0.01 µg/L 239 
(Fig. 2, Fig. S2). The effects of 0.01 µg/L PROP were generally reduced at 48 h pf, except 240 
for GST which appeared significantly down regulated (Fig. 2, Fig. S2). The down 241 
regulation of 5HT1 transcript was further enhanced at 48 h pf, while MeER2 and CS 242 
became significantly down-regulated (Fig. 2, Fig. S2). After exposure to 1 µg/L PROP, at 243 
24 h pf significant upregulation was observed for CS, EP, GST, LYS, MT10, MT20, MytlB, 244 
and MeER2, and down regulation for GUSB, MeER1, MytlC, and 5HT (Fig. 2, Fig. S2). At 245 
48h pf, 1 µg/L PROP caused significant up regulation of all transcripts related to the 246 
antioxidant response (CAT, GST, SOD, Mt10 and MT20), lysosomal function (CTSL, 247 
GUSB and HEX), and of CA and LYS; while a significant downregulation is shown for 248 
5HT1, CS and EP (Fig. 2, Fig. S2).  249 
PERMANOVA and permutation t-test analyses performed on qPCR data showed 250 
that effects of either CBZ or PROP were significant in both embryo stages and at both 251 
concentrations tested (p < 0.05; Table S3 and Table S4, Supplemental material). A 252 
significant interaction between the two factors (developmental stage and CBZ/PROP 253 
treatment) was also reported (p < 0.05; Table S3, Supplemental material). 254 
Fold change variations (log2 transformed) of target transcripts were averaged by 255 
functional group, as defined in Table S2, and the resulting concentration-related 256 
transcriptional profiles at each developmental stage reported in Fig. 3A (CBZ) and Fig. 4A 257 
(PROP). CBZ treatments resulted in complex transcriptional profiles, with consistent up-258 
regulations at 24 h pf (lysosomal responses, immune responses, and putative 259 
neuroendocrine signaling), down-regulations at 48 h pf (shell biogenesis), and bimodal 260 
effects in both embryo stages depending on the tested concentrations (24 h pf: shell 261 


















Fig. 3. Overview of the transcriptional response to CBZ across mussel embryo development. (A) 279 
Graphs report the mRNA expression changes (full squares representing mean values) and the average trend 280 
of variations (lines) within each group of transcripts (defined in Table S2). Detailed data for transcript 281 
expression changes and related statistics are reported in Fig. S2 (B) Distance-based redundancy (DISTLM) 282 
modeling with distance-based redundancy analysis (dbRDA) exploring the amount of the variation in gene 283 
transcription to be attributed to CBZ treatment of M. galloprovincialis embryos at different developmental 284 
stages (Euclidean Distance resemblance matrix, 999 permutations). (C) DISTLM analysis showing 285 
contribution of each functional group to the total variance observed in the CBZ dataset. DISTLM used the 286 
BEST selection procedure and adjusted R2 criteria. Asterisks indicate level of statistical significance related 287 
to the result (**p < 0.01; *p < 0.05). Colored figure is intended only for the online and PDF version  288 
 289 
Distance-based linear model (DISTLM) analyses revealed that expression profiles were 290 
strongly dependent on the time post-fertilization that explained about 89.4% total variation 291 
(Fig. 3B). Nevertheless, CBZ treatment accounted for about 5% total variation explaining 292 
the observed transcriptional changes at the 24 h and 48 h pf (Fig. 3B).  DISTLM analysis 293 
by functional groups also revealed that expression patterns of transcripts involved in 294 
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antioxidant responses, lysosomal responses, putative neuroendocrine signaling, and shell 295 
biogenesis explained the observed effects of CBZ at 24 h and 48 h pf (Fig. 3C). 296 
Responses to CBZ of immune related gene products reached relevance at 48 h pf (p < 297 























Fig. 4. Overview of the transcriptional response to PROP across mussel embryo development. (A) 321 
Graphs report the mRNA expression changes (full squares representing mean values) and the average trend 322 
of variations (lines) within each functional group (defined in Table S2). Detailed data for transcript expression 323 
changes and related statistics are reported in Fig. S2 (B) Distance-based redundancy (DISTLM) modeling 324 
with distance-based redundancy analysis (dbRDA) exploring the amount of the variation in gene transcription 325 
to be attributed to PROP treatment of M. galloprovincialis embryos at different developmental stages 326 
(Euclidean Distance resemblance matrix, 999 permutations). (C) DISTLM analysis showing contribution of 327 
each functional group to the total variance observed in the PROP dataset. DISTLM used the BEST selection 328 
procedure and adjusted R2 criteria. Asterisks indicate level of statistical significance related to the result (**p 329 
< 0.01; *p < 0.05). Colored figure is intended only for the online and PDF version  330 
 331 
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PROP treatments at 24 h pf caused overall up-regulation of transcripts involved in 332 
antioxidant responses and shell biogenesis, down-regulation of transcripts involved in 333 
putative neuroendocrine signaling, and globally unchanged expression patterns of 334 
transcripts encoding lysosomal enzymes and immune-related gene products (Fig. 4A).  335 
At 48 h pf, PROP induced down-regulation of transcripts for shell biogenesis and for 336 
putative neuroendocrine signaling at 0.01 µg/L, and up-regulation of transcripts for 337 
lysosomal and antioxidant responses at 1 µg/L (Fig. 4A). DISTLM showed that expression 338 
profiles strongly depend on the time post-fertilization (89% total variation), with PROP 339 
treatment accounting for about 8% total variation, which mostly explained the observed 340 
transcriptional changes at 48 h pf (Fig. 4B). DISTLM analysis by functional groups showed 341 
that expression patterns of transcripts involved in antioxidant response, immune 342 
responses, shell biogenesis, and, to a lesser extent, lysosomal responses, explained the 343 
observed effects of PROP at 24 h pf (Fig. 4C). The effects of PROP at 48 h pf were mostly 344 
explained by expression patterns of transcripts involved in antioxidant and immune 345 
responses, while putative neuroendocrine signaling and shell biogenesis were of minor 346 
relevance (though statistically significant) (Fig. 4C). 347 
4 Discussion  348 
The 96-microwell embryotoxicity assay has proven as a sensitive methodology for the 349 
high throughput screening of emerging contaminants, including anti-inflammatory, blood 350 
lipid lowering and antidepressant drugs, on embryo development of M. galloprovincialis 351 
(Balbi et al., 2018, 2017a, 2016; Estévez-Calvar et al., 2017; Fabbri et al., 2014). The 352 
present study showed that the antiepileptic drug CBZ and the β-blocker PROP, two 353 
pharmaceuticals widely used in human and veterinary therapies and commonly detected in 354 
marine coastal waters, altered embryo phenotypes, with significant effects observed from 355 
environmental concentrations (in the ng/L range). Although comparable EC50 values were 356 
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obtained in embryotoxicity tests ( 1 µg/L), CBZ mainly induced shell malformations in D-357 
veligers at 48 h pf at all the concentrations tested, whereas PROP resulted in different 358 
percentages of malformed/immature, and progressive developmental arrest/mortality at 359 
concentrations much higher than reported environmental levels. 360 
In order to investigate possible impact of CBZ and PROP on gene expression, the 361 
effects of both compounds on the transcriptional pattern of 17 genes were evaluated in 362 
embryos at both 24 h and 48 h pf. These include both gene sequences corresponding to 363 
known biological functions in adult mussels and embryos (Balbi et al., 2017a, 2016), as 364 
well as genes whose transcription has been shown to be modulated by exposure to other 365 
emerging contaminants in mussel early larval stages (Balbi et al. 2016, 2017a, 2018; 366 
Capolupo et al., 2018). Moreover, expression of genes related to lysosomal function was 367 
evaluated in this study.  368 
Transcriptional effects were investigated at two selected concentrations: 0.01 µg/L, a 369 
value that falls within the range detected in coastal and estuarine waters (see Table S1) 370 
and 1 µg/L (a value around the observed EC50 for both compounds in embriotoxicity 371 
assays). On the whole, the results show that CBZ and PROP induced significant changes 372 
in gene expression at both concentrations and developmental stages.  373 
CBZ and PROP affected transcription of shell-specific transcripts at both post-374 
fertilization times. Previous works indicated that these transcripts are involved in the 375 
homeostasis of carbonate chemistry at the site of calcification (CA, EP) and in organic 376 
matrix synthesis (CS), which control calcification rates and morphology of the shell (Chan 377 
et al., 2018; Kocot et al., 2016; Ramesh et al., 2017). Accordingly, they are strongly up-378 
regulated in the early stages of mussels along with shell formation (Balbi et al., 2017a, 379 
2016). The down-regulation of both EP and CS induced by both compounds at 48 h pf 380 
suggests that CBZ and PROP may interfere with regulation of shell biogenesis.  381 
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Modulation of transcripts encoding for lysosomal enzymes seems a common effect of CBZ 382 
and PROP in developing embryos. In embryos grown in physiological conditions, 383 
expression of lysosomal enzymes HEX and CTSL, and, to a lesser extent, of GUSB 384 
increased dramatically from 24 h to 48 h pf. This is not surprising, since the acquisition of a 385 
suitably functional lysosomal system is related to development of the digestive system, 386 
where intracellular digestion in hepatopancreatic cells represents the main route of food 387 
processing in bivalves (Balbi et al., 2017b), and also endows the animals with an active 388 
detoxification system of waterborne chemicals (Balseiro et al., 2013). Lysosomes may 389 
accumulate pharmaceuticals (in particular lipophilic compounds with amino groups) by pH 390 
partitioning (Kazmi et al., 2013), leading to altered lysosomal functions and drug-drug 391 
interactions (Franzellitti et al., 2015, 2013). The capacity of CBZ and PROP to affect 392 
lysosomes in marine invertebrates was demonstrated by in vivo studies with adult 393 
mussels, clams, and crabs, in which the pharmaceuticals decreased lysosomal membrane 394 
stability in haemocytes (Aguirre-Martinez et al., 2015; Aguirre-Martínez et al., 2013b, 395 
2013a; Franzellitti et al., 2011; Martin-Diaz et al., 2009), or increased neutral lipid contents 396 
in digestive glands, and interactively affected PROP tissue accumulation (Franzellitti et al., 397 
2015). Both CBZ and PROP affected transcription of genes encoding for different 398 
lysosomal enzymes, in particular at 48 hpf. Although the effects were not apparently 399 
concentration-dependent, the results show that the lysosomal function can be affected by 400 
pharmaceuticals also in developing embryos. 401 
CBZ and PROP affected transcription of genes involved in immune and antioxidant 402 
responses, causing up- or down-regulations depending on concentration and the  stage 403 
investigated. In particular, at 24 hpf, immune-related genes were up-regulated in response 404 
to low concentrations of CBZ. Both immunomodulatory and pro-oxidant effects of 405 
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pharmaceuticals have been widely reported in aquatic species (Fabbri and Franzellitti, 406 
2016).  407 
Finally, CBZ and PROP also affected transcription of serotonin and Mytilus estrogen 408 
receptors (5-HT1, MeER1 and MeER2). A putative role for these genes in neuroendocrine 409 
signaling during development was suggested by their strong upregulation from fertilization 410 
to 48 h pf under basal conditions (Balbi et al., 2016). Moreover, their transcription was 411 
affected by exposure to different types of contaminants (i.e. bisphenol A, 17-estradiol, 412 
and styrene) with up and down regulations depending on the chemical and developmental 413 
stage (Balbi et al., 2016; Rasika Wathsala et al., 2018). In particular, the observed 5-HT1 414 
downregulation induced by PROP at the different concentrations and times pf tested, 415 
indicate an overall impact of this compound on the serotoninergic system. 416 
In an attempt to compare the overall impacts of CBZ and PROP on mussel embryos, a 417 
radar plot that summarizes all data on phenotypical and molecular changes is reported in 418 










Fig 5. Radar plot summarizing the embryotoxic and molecular effects of CBZ and PROP in M. 
galloprovincialisearly larval stages. For each biological endpoint, CBZ or PROP concentration-related 
variation is expressed by the Area Under the Curve (AUC) according to Franzellitti et al. (2018). Details for 
AUC calculation are reported in Table S5, Supplemental material. Colored figure is intended only for the 















Although CBZ showed more limited phenotypic outcomes at increasing 429 
concentrations, signatures of molecular effects (antioxidant processes, shell biogenesis, 430 
lysosomal function) which may forecast upcoming changes at the physiological level are 431 
highlighted. For example, the observed changes in lysosomal related gene products in 432 
CBZ-exposed embryos may affect not only the development of the digestive system, but 433 
also degradative pathways supported by lysosomal enzymes that are crucial in embryo 434 
remodeling across development (Dyrynda et al., 1995). 435 
Differently, PROP seems to have a greater impact on development in terms of 436 
embryotoxicity and mortality at higher concentrations. Developmental impairments due to 437 
PROP were previously reported in oysters; these effects were partly ascribed to the 438 
therapeutic action of PROP as an adrenergic antagonist, which may alter the physiological 439 
function of catecholamines in mussel embryo development (Yang et al., 2014). Indeed, 440 
PROP blocked epinephrine-induced metamorphosis in larvae of Crassostrea gigas (Coon 441 
and Bonar, 1987), increased mortality rates in zebrafish embryos, and induced 442 
developmental arrest in sea urchin embryos (Ribeiro et al., 2015). In embryos of the sea 443 
urchin Arbacia lixula, reduced cholinergic and serotoninergic signaling was related to 444 
impaired skeletogenesis and increased morphological abnormalities (Cappello et al., 445 
2017). In this light, additional investigations are needed to understand the effects of PROP 446 
on adrenergic signaling in bivalve development. 447 
5 Conclusions 448 
Overall, the present study supports the use of the 96 microwell embryotoxicity assay 449 
to identify those pharmaceuticals that can provoke major types of morphological 450 
alterations at environmental concentrations.  451 
With regards to data obtained on gene expression, the results indicate that the main 452 
effects on overall transcription (i.e. maximum distance between control and treated 453 
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samples in the DISTLM analysis) were detected at 24 h pf for CBZ and at 48 h pf for 454 
PROP. In particular, as shown by the heatmap analysis, the impact of CBZ was evident at 455 
concentrations as low as 0.01 g/L. 456 
The results as a whole do not reveal a clear pattern in response to different 457 
concentrations of CBZ and PROP. In this light, present data do not provide evidence for a 458 
major or distinct mechanism of action for either compound, but they may reflect an 459 
adaptation response to exposure to these pharmaceuticals.  460 
However, these are the first data demonstrating that both CBZ and PROP, at 461 
concentrations encompassing environmental levels, can interfere with multiple processes 462 
in mussel early development. Together with recent studies (Balbi et al., 2018, 2016), these 463 
observations raise new concerns on the occurrence of pharmaceuticals in coastal 464 
environments and their potential impacts on marine fauna. This information can be used to   465 
address further investigations on the possible molecular targets and mechanisms of action 466 
for either compound, and eventually contribute to establish regulatory priorities to limit the 467 
environmental occurrence of these emerging contaminants. 468 
 469 
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